INNOVATION PHARMACEUTICAL (IPIX) Total Assets by Year
INNOVATION PHARMACEUTICAL closed fiscal year 2023 with $7.5M in total assets, $5.5M in total liabilities and $2.0M in shareholder equity. This represents a decrease of 27.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters INNOVATION PHARMACEUTICAL has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IPIX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.5M-27.6% | $10.4M-27.4% | $14.3M+54.6% | $9.2M+128.6% | $4.0M-38.1% | $6.5M-28.2% | $9.1M-20.4% | $11.4M-20.1% | $14.3M+31.9% | $10.9M+265.4% | $3.0M+10496.5% | $28K-91.0% | $313K | N/A | N/A |
| Total Liabilities | $5.5M-3.0% | $5.6M-16.8% | $6.8M-12.8% | $7.8M-4.8% | $8.2M-5.9% | $8.7M-17.8% | $10.6M+24.7% | $8.5M+16.3% | $7.3M-24.4% | $9.6M+18.5% | $8.1M+6.3% | $7.7M+0.7% | $7.6M | N/A | N/A |
| Total Equity | $2.0M-56.9% | $4.7M-37.0% | $7.5M+413.6% | $1.5M+135.4% | -$4.1M-92.0% | -$2.2M-46.9% | -$1.5M-149.4% | $3.0M-57.8% | $7.0M+482.4% | $1.2M+123.3% | -$5.2M+32.2% | -$7.6M-4.6% | -$7.3M-51.9% | -$4.8M-167.6% | -$1.8M |
IPIX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.7M-28.6% | $7.5M-27.6% | $8.0M-31.4% | $8.7M-33.5% | $9.3M-36.6% | $10.4M-27.4% | $11.7M-31.1% | $13.1M+5.3% | $14.7M+26.0% | $14.3M+54.6% | $16.9M+322.2% | $12.4M+255.0% |
| Total Liabilities | $5.5M-7.0% | $5.5M-3.0% | $5.3M-9.7% | $5.6M-8.4% | $5.9M-8.0% | $5.6M-16.8% | $5.8M-13.0% | $6.1M-31.8% | $6.4M-8.4% | $6.8M-12.8% | $6.7M-20.8% | $9.0M-1.5% |
| Total Equity | $1.2M-66.0% | $2.0M-56.9% | $2.7M-53.3% | $3.1M-55.6% | $3.4M-58.8% | $4.7M-37.0% | $5.8M-43.0% | $6.9M+102.1% | $8.3M+77.7% | $7.5M+413.6% | $10.2M+328.2% | $3.4M+161.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More INNOVATION PHARMACEUTICAL financials
Frequently Asked Questions
What was INNOVATION PHARMACEUTICAL's total assets in fiscal year 2023?
INNOVATION PHARMACEUTICAL closed fiscal year 2023 with $7.5M in total assets, $5.5M in total liabilities and $2.0M in shareholder equity.
How fast is INNOVATION PHARMACEUTICAL's total assets growing?
INNOVATION PHARMACEUTICAL (IPIX) total assets fell by 27.6% year over year, from $10.4M to $7.5M in fiscal year 2023.
What was INNOVATION PHARMACEUTICAL's total assets in the most recent quarter?
INNOVATION PHARMACEUTICAL (IPIX) reported $6.7M in total assets in Q1 2024. This represents a decrease of 28.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what INNOVATION PHARMACEUTICAL (IPIX) reported on that line in every period on record.